FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.
What happened
FDA inspected the contract testing laboratory in Grand Prairie, Texas, from May 7 to 17, 2024. The agency found that Analytical Food Laboratories used unvalidated assay methods, lacked written assay procedures, performed HPLC without proper system suitability, and used growth media tested with only one microorganism, among other quality-unit and documentation failures. The letter says the lab performed chemical and/or microbiological testing on at least (b)(4) customer drug samples from January 2022 to May 2024.
What FDA found
The lab failed to adequately validate analytical methods used to test customers' drug products and lacked written procedures for the assay method.
21 CFR 211.160(a) and 211.160(b)HPLC analyses lacked an appropriate system suitability determination before sample injections.
21 CFR 211.160(b)Growth promotion testing of microbiological media used only Staphylococcus aureus and did not include all USP <61> challenge microorganisms.
21 CFR 211.160(b)The quality control unit failed to adequately control issuance and reconciliation of uncontrolled loose forms used for laboratory testing, equipment use, and calibrations.
21 CFR 211.22The quality unit failed to review laboratory records for completeness, including documentation of blank, sample, and mobile phase preparations.
21 CFR 211.22The quality manual and SOP referenced 21 CFR 58.35, but procedures did not detail how operations would meet 21 CFR parts 210 and 211.
21 CFR 211.22
What FDA wants
FDA tells the company to respond in writing within 15 working days with what it has done to address the violations and prevent recurrence. It also asks for comprehensive independent assessments and remediation plans for laboratory practices, a 3-year retrospective risk assessment of chemical and microbiological testing, customer notification of deficiencies, and quality unit/documentation/change management reviews.
Who should pay attention
- drug manufacturers that rely on this contract lab for release testing
- companies using Analytical Food Laboratories for chemical or microbiological testing
- quality units at contract testing laboratories
This is a summary. Read the original letter on fda.gov.